COVAKRAS Trademark

Trademark Overview


On Wednesday, November 13, 2019, a trademark application was filed for COVAKRAS with the United States Patent and Trademark Office. The USPTO has given the COVAKRAS trademark a serial number of 88690330. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 12, 2021. This trademark is owned by Amgen Inc.. The COVAKRAS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amylodiosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders
covakras

General Information


Serial Number88690330
Word MarkCOVAKRAS
Filing DateWednesday, November 13, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 12, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 14, 2020

Trademark Statements


Goods and Servicespharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amylodiosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 19, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events


Event DateEvent Description
Monday, April 12, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 12, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 8, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 14, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 24, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 10, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 9, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 8, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 8, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 27, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 27, 2019NON-FINAL ACTION E-MAILED
Friday, December 27, 2019NON-FINAL ACTION WRITTEN
Thursday, December 26, 2019ASSIGNED TO EXAMINER
Tuesday, November 19, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 16, 2019NEW APPLICATION ENTERED IN TRAM